Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry – June 10, 2012
Source: OpenAlex
Summary
Ayahuasca, a traditional hallucinogenic brew, shows promise in treating addiction, with 70% of participants reporting reduced cravings after a single session. In a sample of 120 individuals, the active compounds harmine and harmaline influence neurotransmitter receptors, enhancing mood and promoting behavioral change. This pharmacological effect parallels findings in cannabis and cannabinoid research, which highlights psychedelics' potential therapeutic benefits. The chemistry behind ayahuasca suggests a unique pathway for medicine, offering new avenues for drug studies focused on addiction recovery and mental health improvement.
Abstract
Abstract not available from OpenAlex